Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.
Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 8, 2016 | Series C | $100M | 1 | — | — | Detail |
Dec 2, 2014 | Grant | $179.99K | 1 | National Science Foundation | — | Detail |
Apr 9, 2013 | Grant | $1.31M | 1 | National Science Foundation | — | Detail |
Dec 10, 2012 | Grant | $180K | 1 | National Science Foundation | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 12, 2019
Synlogic
|
Post-IPO Equity | $80M | Biotechnology | Yes |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
Allen & Company | — | Series C |